Crossmark

Generalizability of kidney and cardiovascular protection by finerenone to the <i>real world</i> in Italy: insights from Fidelio and Figaro studies

Crossref DOI link: https://doi.org/10.1007/s40620-024-02171-8

Published Online: 2024-12-15

Published Print: 2025-03-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

De Cosmo, Salvatore

Pontremoli, Roberto

Giandalia, Annalisa https://orcid.org/0000-0002-0778-4130
Manicardi, Valeria

Rocca, Alberto

Nicolucci, Antonio

Rossi, Maria Chiara

Lucisano, Giuseppe

Graziano, Giusi

Di Bartolo, Paolo

Di Cianni, Graziano

Candido, Riccardo

Russo, Giuseppina T.

,
Funding

Funding for this research was provided by:

This research received external funding from the Association of Medical Diabetologists (Associazione Medici Diabetologi, AMD).

This research received external funding from the Association of Medical Diabetologists (Associazione Medici Diabetologi, AMD).
License Information

Version of Record valid from 2024-12-15

Text and Data Mining valid from 2024-12-15

Version of Record valid from 2024-12-15
More Information

Article History

Received: 3 June 2024

Accepted: 16 November 2024

First Online: 15 December 2024

Declarations

:

: The authors have no competing interests to disclose.

: Local ethics committees of each participating center approved the study protocol.

: All Authors declare: this research did not involve animals. The research was conducted on human subjects, following procedures in accordance with the ethical standards of the responsible Committees (this is a retrospective multicenter study) on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008.

: Given the anonymous nature of the study, based on the Italian regulations, informed consent is not requested.